Other Clinical Trial - Future Patient - Telerehabilitation of Heart

Status Completed

Clinical Trial Summary

The idea behind the Future Patient research project is to develop a telerehabilitation program and tools for patients with heart failure. The hypothesis for this study is that participation in a telerehabilitation program for patients with heart failure will increase the patients' quality of life and multi-parametric (subjective and objective) individualized monitoring in a telerehabilitation program for patients with heart failure will increase detection of worsening of symptoms and avoid future hospitalization of the HF-patients.

Clinical Trial Description

The overall aim is to test, implement and evaluate a telerehabilitation program for patients with heart failure from clinical, psychosocial, health literacy and e-health literacy, inter-organizational, health economic and technical perspectives. Furthermore, this study has sub aims: - To increase the quality of life for patients with Heart Failure (HF) - To optimize the medical treatment of patients with HF - To perform multi-parametric (subjective and objective) individualized monitoring in order to detect worsening of symptoms and avoid hospitalizations - To increase physical activities for patients with heart failure in everyday life in a telerehabilitation program - To facilitate patient-initiated self-care management actions upon the following early detection of changes in source data (steps taken, weight, blood pressure, pulse, sleep, illness perception, motivation, anxiety and depression) - To evaluate patients health literacy and e-health literacy participating in a telerehabilitation program and rehabilitation program - To test and evaluate the Heart Portal - a digital toolbox for improved self-management for patients with heart failure and their relatives - To explore the experiences and perspectives of the patients and their relatives when being part of a telerehabilitation program - To test and evaluate a cross sector communication platform from a patient and healthcare professional perspective - To perform a cost-effectiveness analysis of total costs of healthcare and rehabilitation services ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03388918
Study type	Interventional
Source	Aalborg University
Contact
Status	Completed
Phase	N/A
Start date	December 21, 2016
Completion date	August 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04049045` - Effects of Empagliflozin on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure	Phase 2
Active, not recruiting	`NCT05100836` - SURPASS Impella 5.5 Study
Recruiting	`NCT02898181` - Low Level Tragus Stimulation in Acute Decompensated Heart Failure	N/A
Completed	`NCT02823626` - High-dose Aldosterone Antagonist for Acute Decompensated Heart Failure
Completed	`NCT02248831` - Evaluation of Cardiopulmonary Diseases by Ultrasound	N/A
Completed	`NCT02196038` - A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients	N/A
Completed	`NCT00693745` - Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF	N/A
Not yet recruiting	`NCT04391231` - HEMolysis in a Percutaneous Axial Flow LVAD, Effects of Pentoxifylline in a Randomized Controlled Trial	Phase 4
Recruiting	`NCT05206422` - DORAYA-HF Early Feasibility Study	N/A
Recruiting	`NCT01960218` - Gas Exchange for Predicting Hospital Heart Failure Readmissions	N/A
Terminated	`NCT00904488` - Oral Metolazone and Intermittent Intravenous Furosemide Versus Continuous Infusion Furosemide in Acute Heart Failure	Phase 4
Terminated	`NCT02620384` - Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.	Phase 3
Completed	`NCT04318093` - Study of the Safety of BMS-986259 in Participants With Post-Acute Decompensated Heart Failure	Phase 2
Recruiting	`NCT06161649` - Mobile Education System to Improve Disease Knowledge, Self-efficacy and Quality of Life in Patients With Heart Failure	N/A
Completed	`NCT02289508` - Role of USCOM in Adult Patients With Heart Failure	N/A
Terminated	`NCT01457053` - Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics	N/A
Completed	`NCT04877652` - DR REGISTRY: Prospective Observational Study of ADHF Patients With Insufficient Response to Diuretics
Completed	`NCT03505788` - Acetazolamide in Decompensated Heart Failure With Volume OveRload (ADVOR)	Phase 4
Completed	`NCT03146754` - A Study to Evaluate Lung Ultrasound as a Method to Measure Changes in Extravascular Lung Water Induced by Positional Changes (LUPE)	N/A
Terminated	`NCT05346653` - The Hemodynamic Effects of SGLT2i in Acute Decompensated Heart Failure	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Future Patient - Telerehabilitation of Heart Failure Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms